AstraZeneca Plans to Seek Regulatory Approval for COPD Drug PT010 Following Phase III Trial Sep 17, 2018 Life Science
Chinese online chemist 111 looks beyond lacklustre Nasdaq debut to strong growth at wholesale unit Sep 13, 2018 Life Science
Zai Lab Pays $15 Million for China Rights to Electric Field Therapy for Brain Cancer Sep 13, 2018 Life Science
First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody as First-line Treatment for Patients with Non-Squamous Non-Small Cell Lung Cancer Sep 11, 2018 Life Science
Tianjin Tasly Out-licenses US Rights to TCM Angina Drug in $50 Million Deal Sep 11, 2018 Life Science
